I wouldn’t use those costs as they are European and from 2001. It is better to use the current sales prices of AML new drugs which are in the range of US$200-450K per patient.
Assume 20% of all AML cases are extramedullary, this amounts to around 4000 case in the USA and 6000 in the rest of the developed world. I will leave it to you guys to do the rest of the maths using whatever number you like on the percentage of patients that might use bisantrene.
- Forums
- ASX - By Stock
- RAC
- Ann: Bisantrene data published in European Journal of Haematology
RAC
race oncology ltd
Add to My Watchlist
0.41%
!
$1.23

Ann: Bisantrene data published in European Journal of Haematology, page-25
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.23 |
Change
0.005(0.41%) |
Mkt cap ! $213.7M |
Open | High | Low | Value | Volume |
$1.24 | $1.25 | $1.23 | $27.28K | 22.06K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 168 | $1.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.24 | 499 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 168 | 1.230 |
1 | 250 | 1.225 |
3 | 1266 | 1.220 |
2 | 10640 | 1.215 |
1 | 640 | 1.205 |
Price($) | Vol. | No. |
---|---|---|
1.235 | 499 | 1 |
1.245 | 1709 | 1 |
1.250 | 6620 | 2 |
1.255 | 6857 | 1 |
1.260 | 6015 | 2 |
Last trade - 11.38am 11/08/2025 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |